YIK WO INTL (08659) plans to sell 100% equity of Yizhen Film and Television Media Co., Ltd. for 15 million yuan.
E-Horizon International Holdings (08659) announced that it plans to sell 100% equity of Yizhen Film and Television Media Co., Ltd. to Xiamen Rongdeng Shengshi International Trade Co., Ltd. on December 31, 2025 for a price of 15 million yuan.
YIK WO INTL (08659) announced that on December 31, 2025, the company plans to sell 100% equity of Yizhen Media Co., Ltd. to Xiamen Rongdeng Shengshi International Trading Co., Ltd. for a price of 15 million RMB.
The target company holds a 10% stake in a film project tentatively titled "Ingelit" in the commercial literary film. The company acquired all the issued shares of the target company in 2022, accounting for 10% of the investment amount, and can share 10% of the profits of the film. At the relevant time, the film has completed shooting and is in post-production. It is expected to obtain the approval of the Chinese government for release and complete post-production shortly after approval. However, as of the date of this announcement, the film still does not have a specific release schedule, and the company's investment in the film continues to face significant uncertainties and risks. In view of the above situation and the existing interested buyers, the directors believe that selling the sales shares to use the proceeds for the group's operating funds is in the interest of the company.
Related Articles

US Stock Market Move | Partial encrypted mining enterprises concept fluctuated and rose. TeraWulf (WULF.US) surged nearly 5%.

US Stock Market Move | Fujian Eastern Red (ORIS.US) Soars Over 25% and Plans to Acquire Controlling Stake in Hubei Daguan Tea Industry Group.

US Stock Market Move | New antiemetic drug Nereus approved by FDA, Vanda Pharmaceuticals Inc. (VNDA.US) surges over 32%
US Stock Market Move | Partial encrypted mining enterprises concept fluctuated and rose. TeraWulf (WULF.US) surged nearly 5%.

US Stock Market Move | Fujian Eastern Red (ORIS.US) Soars Over 25% and Plans to Acquire Controlling Stake in Hubei Daguan Tea Industry Group.

US Stock Market Move | New antiemetic drug Nereus approved by FDA, Vanda Pharmaceuticals Inc. (VNDA.US) surges over 32%






